Kristin Brooks01.26.21
Adare Pharma Solutions, a global technology-driven CDMO, is opening a new small-scale development lab in Vandalia, OH.
Adare built the non-GMP lab with two rooms that are physically separated from the FDA, GMP certified pilot and production areas. This new lab space offers customizable, flexible systems designed to expedite formulation and process development services.
“The new small-scale laboratory is part of Adare’s dedication to provide customers more early stage development capacity and drive decreased timelines for new projects,” said Giovanni Ortenzi, Adare’s Vice President, Pharmaceutical Development & Chief Technical Officer.
The new laboratory leverages smaller development equipment mirroring Adare’s pilot and production capabilities to enable the production of smaller batches using less active pharmaceutical ingredients (APIs). The additional space will allow Adare to provide customers with immediate-release, modified release, taste-masked, or other custom formulation solutions through its proprietary technologies to help with faster development timelines with reduced drug consumption.
Adare built the non-GMP lab with two rooms that are physically separated from the FDA, GMP certified pilot and production areas. This new lab space offers customizable, flexible systems designed to expedite formulation and process development services.
“The new small-scale laboratory is part of Adare’s dedication to provide customers more early stage development capacity and drive decreased timelines for new projects,” said Giovanni Ortenzi, Adare’s Vice President, Pharmaceutical Development & Chief Technical Officer.
The new laboratory leverages smaller development equipment mirroring Adare’s pilot and production capabilities to enable the production of smaller batches using less active pharmaceutical ingredients (APIs). The additional space will allow Adare to provide customers with immediate-release, modified release, taste-masked, or other custom formulation solutions through its proprietary technologies to help with faster development timelines with reduced drug consumption.
